Interactions of phenylalanine derivatives with human tyrosinase: lessons from experimental and theoretical studies
Clarisse Faure,Yi Ming Ng,Catherine Belle,Montserrat Soler-Lopez,Lyna Khettabi,Melissa Saidi,Nathalie Berthet,Marc Maresca,Christian Philouze,Walid Rachidi,Marius Reglier,Amaury du Moullinet d'Hardemare,Hélène Jamet
DOI: https://doi.org/10.1002/cbic.202400235
IF: 3.2
2024-04-21
ChemBioChem
Abstract:The pigmentation of the skin, modulated by different actors in melanogenesis, is mainly due to the melanins (protective pigments). In humans, these pigments' precursors are synthetized by an enzyme known as tyrosinase (TyH). The regulation of the enzyme activity by specific modulators (inhibitors or activators) can offer a means to fight hypo‐ and hyper‐pigmentations responsible for medical, psychological and societal handicaps. Herein, we report the investigation of phenylalanine derivatives as TyH modulators. Interacting with the binuclear copper active site of the enzyme, phenylalanine derivatives combine effects induced by combination with known resorcinol inhibitors and natural substrate/intermediate (amino acid part). Computational studies including docking, molecular dynamics and free energy calculations combined with biological activity assays on isolated TyH and in human melanoma MNT‐1 cells, and X‐ray crystallography analyses with the TyH analogue Tyrp1, provide conclusive evidence of the interactions of phenylalanine derivatives with human tyrosinase. In particular, our findings indicate that an analogue of L‐DOPA, namely (S)‐3‐amino‐tyrosine, stands out as an amino phenol derivative with inhibitory properties against TyH.
biochemistry & molecular biology,chemistry, medicinal